Search
healthcare › clinical-trials › h-54088
… and safety of suvecaltamide in the treatment of moderate to severe residual tremor in participants with Parkinson's … The purpose of this study is to evaluate suvecaltamide in Parkinson’s disease … A study of suvecaltamide in the treatment of moderate to severe residual tremor from Parkinson's disease …
healthcare › clinical-trials › h-56035
… in Patients With PD-L1 CPS Advanced Gastric and Esophageal Adenocarcinoma … This phase II/III trial compares the addition of nivolumab to the usual treatment of paclitaxel and ramucirumab to paclitaxel and … PARAMUNE Trial: Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer …
academic-centers › ... › policy-research
… of Genomics, and Medical Decision Making and Ethics. Visit the link below to view a list of the currently funded …
education › ... › attendance-tracking
… Many instructors who teach face-to-face and blended courses use attendance data as part of … and institutions also use attendance data in these ways: International students who must maintain visas may … What is the Attendance tool in Blackboard? …
research › ... › research-background
… in how chromatin appears to function in complex multivalent ways. That is more than one source of variability is … domains that read more than one PTM simultaneously. In this way signals may be integrated and more complex information … single protein molecule there can be trillions of possible ways in which they can combine to define unique species …
healthcare › clinical-trials › h-44098
… Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn’s Disease. … The purpose of this study is to test the effectiveness of the study drug oral ozanimod as a treatment for moderately to severely active Crohn’s Disease (CD). … diagnosis of Crohn’s Disease (CD) at least 3 months prior to enrollment; You are experiencing symptoms of abdominal …
news › baylor-and-texas-childrens-collaborate-with-incepta-vaccine-ltd-to-develop-a-covid-19-vaccine-for-bangladesh
… Texas Children’s Hospital and Incepta Vaccine Ltd. today announced a licensing agreement for the development of … vaccine. Incepta Vaccine Ltd. is a vaccine manufacturing company founded in 2011 that provides high-quality vaccines … with Texas Children’s Hospital and Incepta.” “Incepta has always been keen to acquire new and innovative technology for …
news › baylor-moroccan-ministry-of-health-and-social-protection-and-others-collaborate-to-advance-health-in-africa
… the Societe Therapeutique Marocaine (SOTHEM) laboratory, and Regenlab recently convened to sign a memorandum of understanding in Had Soualemm, … Baylor’s efforts under this memorandum. “Global healthcare today requires nimble and innovative approaches. By … of Health and Social Protection and others collaborate to advance health in Africa …
news › successful-first-in-human-implantation-of-the-bivacor-total-artificial-heart-by-baylor-and-thi-doctors
… Medical Center and Baylor College of Medicine announced today the successful first-in-human implantation of the BiVACOR Total Artificial Heart (TAH) as part of the U.S. Food and … single moving part that utilizes a magnetically levitated rotor that pumps the blood and replaces both ventricles of a …